Formulated muco-regulatory agents in the airways of patients with cystic fibrosis

2008
Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy
Shur, J., Nevell, T., Ewen, R., Price, R., Smith, A., Barbu, E., Conway, J., Carroll, M., Shute, J. & Smith, J., 2008, In: Journal of Pharmaceutical Sciences. 97, 11, p. 4857-4868 12 p.
Research output: Contribution to journal › Article › peer-review
The spray drying of unfractionated heparin: optimization of the operating parameters
Shur, J., Nevell, T., Shute, J. & Smith, J., 2008, In: Drug Development and Industrial Pharmacy. 34, 6, p. 559-568 10 p.
Research output: Contribution to journal › Article › peer-review
2007
Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics
Broughton-Head, V., Smith, J., Shur, J. & Shute, J., Dec 2007, In: Pulmonary Pharmacology & Therapeutics. 20, 6, p. 708-717 10 p.
Research output: Contribution to journal › Article › peer-review
Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis
Broughton-Head, V., Shur, J., Carroll, M., Smith, J. & Shute, J., 2007, In: American Journal of Physiology: Lung, Cellular and Molecular Physiology. 293, 5, p. L1240-L1249
Research output: Contribution to journal › Article › peer-review

Research output